Partnering in Oncogenetic Research – The INHERIT BRCAs Experience: Opportunities and Challenges

[1]  P. Pharoah,et al.  Ethical, legal and social implications of genetics , 2007 .

[2]  H. Nevanlinna,et al.  Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families , 2005, Human Genetics.

[3]  J. Simard,et al.  HRT use among women tested for BRCA1/2 mutations following publication of the women's health initiative study results. , 2005, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[4]  J M Grimshaw,et al.  Effectiveness and efficiency of guideline dissemination and implementation strategies , 2004, International Journal of Technology Assessment in Health Care.

[5]  J. Simard,et al.  Changes in health-related behaviours following BRCA 1/2 genetic testing: the case of hormone replacement therapy. , 2004, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[6]  F. Collins,et al.  The family history--more important than ever. , 2004, The New England journal of medicine.

[7]  J. Witte,et al.  Increased power for case‐control studies of single nucleotide polymorphisms through incorporation of family history and genetic constraints , 2004, Genetic epidemiology.

[8]  Douglas F. Easton,et al.  Association studies for finding cancer-susceptibility genetic variants , 2004, Nature Reviews Cancer.

[9]  K. Hemminki,et al.  Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans , 2004, Journal of Medical Genetics.

[10]  F. Couch,et al.  Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. , 2004, American journal of human genetics.

[11]  B. Kramer,et al.  Cancer prevention and the American Society of Clinical Oncology. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  L. McKee,et al.  Family Communication about Genetic Risk: The Little That Is Known , 2004, Public Health Genomics.

[13]  B. Knoppers,et al.  Genetics and Life Insurance: A Comparative Analysis , 2004 .

[14]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[15]  D. Horsman,et al.  Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. , 2004, Journal of the National Cancer Institute.

[16]  Nazneen Rahman,et al.  CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. , 2004, American journal of human genetics.

[17]  David Altshuler,et al.  Organizational challenges in clinical genomic research , 2004, Nature.

[18]  B. Knoppers,et al.  Physicians, genetics and life insurance , 2004, Canadian Medical Association Journal.

[19]  A. Lesur,et al.  Identification et prise en charge des prédispositions héréditaires aux cancers du sein et de l‘ovaire (mise à jour 2004) , 2004 .

[20]  H. Sobol,et al.  [Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004)]. , 2004, Bulletin du cancer.

[21]  B. Godard,et al.  Expanding the physician's duty of care: a duty to recontact? , 2004, Medicine and law.

[22]  J. Witte,et al.  Comparison of missing data approaches in linkage analysis , 2003, BMC Genetics.

[23]  D. Easton,et al.  EMGM Abstracts , 2003, Genetic epidemiology.

[24]  C. Lenfant.  Shattuck lecture--clinical research to clinical practice--lost in translation? , 2003, The New England journal of medicine.

[25]  Lois Peters,et al.  Managing Interdisciplinary, Longitudinal Research Teams: Extending Grounded Theory-Building Methodologies , 2003, Organ. Sci..

[26]  J. Hopper,et al.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.

[27]  A. Wallgren,et al.  Population study on brca mutations in women with breast and ovarian cancers in western Sweden , 2003 .

[28]  Muin J Khoury,et al.  Research priorities for evaluating family history in the prevention of common chronic diseases. , 2003, American journal of preventive medicine.

[29]  Genetic testing for BRCA1 mutation in the UK , 2003, The Lancet.

[30]  A. R. Horwitz.  Building bridges through collaboration--a pathway for interdisciplinary research. , 2003, Trends in cell biology.

[31]  Nhs Confederation.  Our inheritance, our future: realising the potential of genetics in the NHS (DOH White Paper) , 2003 .

[32]  Peter Griffiths,et al.  Methodological strategies for the identification and synthesis of 'evidence' to support decision-making in relation to complex healthcare systems and practices. , 2002, Nursing inquiry.

[33]  Douglas F. Easton,et al.  Polygenic susceptibility to breast cancer and implications for prevention , 2002, Nature Genetics.

[34]  S. Narod.  Modifiers of risk of hereditary breast and ovarian cancer , 2002, Nature Reviews Cancer.

[35]  M. Dugas,et al.  Support groups for people carrying a BRCA mutation. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[36]  J. Emery,et al.  Common hereditary cancers and implications for primary care , 2001, The Lancet.

[37]  P. Pharoah.  Genetics and Public Health in the 21st Century: Using Genetic Information to Improve Health and Prevent Disease , 2001, BMJ : British Medical Journal.

[38]  Bruce A.J. Ponder,et al.  Cancer genetics , 2001, Nature.

[39]  C. Scriver.  Human Genetics: Lessons from Quebec Populations1 , 2001 .

[40]  C. Scriver.  Human genetics: lessons from Quebec populations. , 2001, Annual review of genomics and human genetics.

[41]  K. Shiraki,et al.  Breast cancer genetics: what we know and what we need , 2001, Nature Medicine.

[42]  E. Thomson,et al.  Genetics and Public Health in the 21st Century , 2000 .

[43]  C. Dr.  Status report. Canadian association of provincial cancer agencies. , 2000 .

[44]  D. Carlow.  Status report. Canadian association of provincial cancer agencies. , 2000, Chronic diseases in Canada.

[45]  J. Chang-Claude,et al.  Current Policies for Surveillance and Management in Women at Risk for Breast and Ovarian Cancer: A Survey among 16 European Family Cancer Clinics , 2002, Disease Markers.

[46]  Richard N. Zare,et al.  Interdisciplinary Research: From Belief to Reality , 1999, Science.

[47]  H. Noorani.  PREDICTIVE GENETIC TESTING FOR BREAST AND PROSTATE CANCER , 1999 .

[48]  J. Chang-Claude,et al.  Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group. , 1998, European journal of cancer.

[49]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[50]  L. Skene.  Patients' rights or family responsibilities? Two approaches to genetic testing. , 1998, Medical law review.

[51]  J. Benkendorf,et al.  Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility. , 1997, American journal of medical genetics.

[52]  H. Tsuda,et al.  BRCA1 andBRCA2 germline mutations in Japanese with hereditary breast cancer families , 1997 .

[53]  F. W. Lancaster,et al.  Types and Levels of Collaboration in Interdisciplinary Research in the Sciences , 1997, J. Am. Soc. Inf. Sci..

[54]  T. Sugimura,et al.  BRCA2 germline mutations in Japanese breast cancer families , 1997, International journal of cancer.

[55]  E. Thomson,et al.  Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2 , 1997 .

[56]  K Offit,et al.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. , 1997, JAMA.

[57]  E. Thomson,et al.  Recommendations for Follow-up Care of Individuals With an Inherited Predisposition to Cancer: I. Hereditary Nonpolyposis Colon Cancer , 1997 .

[58]  P. Tonin,et al.  Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? , 1997, American journal of human genetics.

[59]  Lawrence Butler,et al.  'History: Theory and Practice' , 1997 .

[60]  A. Baum,et al.  Stress and genetic testing for disease risk. , 1997, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[61]  S. Berrol.  Interdisciplinarity: History, Theory, and Practice , 1992 .

[62]  Julie Thompson Klein,et al.  Interdisciplinarity: History, theory, and practice. , 1992 .

[63]  Illinois.,et al.  Cancer Genetics , 1976, British Journal of Cancer.